Ironwood Pharmaceuticals Inc - Ordinary Shares - Class A

+0.02 (+0.19%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)2.19B
Current PE4.30
Forward PE 5.31
2yr Forward PE 9.4
See more stats
Estimates Current Quarter
Revenue$105.22 Million
Adjusted EPS$0.31
See more estimates
10-Day MA$13.54
50-Day MA$13.13
200-Day MA$11.79
See more pivots

Ironwood Pharmaceuticals Inc - Ordinary Shares - Class A Stock, NASDAQ:IRWD

100 Summer Street, Suite 2300, Boston, Massachusetts 02110
United States of America
Phone: +1.617.621.7722
Number of Employees: 232


Ironwood Pharmaceuticals, Inc. is a healthcare company, which focuses on the development and commercialization of Gastrointestinal (GI) product opportunities in areas of significant unmet need, leveraging demonstrated expertise and capabilities in GI diseases. Its products include linaclotide, a guanylate cyclase type-C agonists which treats patients irritable bowel syndrome with constipation and chronic constipation. The company was founded by Peter M. Hecht, Eric F. Summers, G. Todd Milne, Brian M. Cali, Joseph C. Cook Jr., and Gina Bornino Miller on January 5, 1998 and is headquartered in Boston, MA.